A

nonprofit that often puts drug makers on edge with reports about the value of medicines may become still more controversial with plans to sound off about “unjustified price increases.”

The Institute for Clinical and Economic Review, which has become influential as a sort of cost-effectiveness watchdog for the pharmaceutical industry, expects to issue an annual report on price hikes thanks to a fresh round of backing from the Laura and John Arnold Foundation.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.